Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies

por Moch, C, Moysan, A, Lubin, R, Salmonière, P de La, Soufir, N, Galisson, F, Vilmer, C, Venutolo, E, Pelletier, F Le, Janin, A, Basset-Séguin, N
Publicado 2001

MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma

por Xiong, J, Wang, L, Fei, X-C, Jiang, X-F, Zheng, Z, Zhao, Y, Wang, C-F, Li, B, Chen, S-J, Janin, A, Gale, R P, Zhao, W-L
Publicado 2017

Changes in allelic imbalances in locally advanced breast cancers after chemotherapy

por Varna, M, Soliman, H, Feugeas, J-P, Turpin, E, Chapelin, D, Legrès, L, Plassa, L-F, de Roquancourt, A, Espié, M, Misset, J-L, Janin, A, de Thé, H, Bertheau, P
Publicado 2007

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches

por Lehmann-Che, J, Amira-Bouhidel, F, Turpin, E, Antoine, M, Soliman, H, Legres, L, Bocquet, C, Bernoud, R, Flandre, E, Varna, M, de Roquancourt, A, Plassa, L-F, Giacchetti, S, Espié, M, de Bazelaire, C, Cahen-Doidy, L, Bourstyn, E, Janin, A, de Thé, H, Bertheau, P
Publicado 2011